1. The Role of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in the Management of Diabetic Complications

   • Toomas Podar
   • Jaakko Tuomilehto

   Leading Article 10 October 2012 Pages: 2007 - 2012

2. The Clinical Value of Erythropoietin in Patients with Cancer

   • Ulrich Dührsen

   Leading Article 10 October 2012 Pages: 2013 - 2023

   

3. Premenopausal Breast Cancer

   • Herbert G. Sayer
   • Roland Kath
   • Klaus Höffken

   Review Article 10 October 2012 Pages: 2025 - 2038

   

4. Camptothecins

   • Hulya Ulukan
   • Peter W. Swaan

   Review Article 10 October 2012 Pages: 2039 - 2057

   

5. Valdecoxib

   • Douglas Ormrod
   • Ken Wellington
   • Antona J. Wagstaff

   Adis New Drug Profile 10 October 2012 Pages: 2059 - 2071

   

6. Valdecoxib

   • Frank A. Wollheim

   Adis New Drug Profile 10 October 2012 Pages: 2072 - 2072

7. Valdecoxib

   • Tim Warner

   Adis New Drug Profile 10 October 2012 Pages: 2072 - 2073

8. Rosuvastatin

   • Christopher I. Carswell
   • Greg L. Plosker
   • Blair Jarvis

   Adis New Drug Profile 10 October 2012 Pages: 2075 - 2085

   

9. Rosuvastatin

   • Anders C. Olsson

   Adis New Drug Profile 10 October 2012 Pages: 2086 - 2086

10. Rosuvastatin

    • James D. Best

    Adis New Drug Profile 10 October 2012 Pages: 2086 - 2086

11. Rosuvastatin

    • Pang H. Chong

    Adis New Drug Profile 10 October 2012 Pages: 2086 - 2087

12. Polyethylene Glycol-Liposomal Doxorubicin

    • Miriam Sharpe
    • Stephanie E. Easthope
    • Harriet M. Lamb

    Adis Drug Evaluation 10 October 2012 Pages: 2089 - 2126

    

13. Levofloxacin

    • Miriam Hurst
    • Harriet M. Lamb
    • David P. Figgitt

    Apis Drug Evaluation 10 October 2012 Pages: 2127 - 2167